DXC
DXC Technology Company
DXC trails on the overall score without a compensating advantage in the available component scores.
MU
Micron Technology, Inc.
MU has the edge over DXC overall, supported by stronger valuation and stronger fundamentals.
DXC Fundamentals
| Metric | Status |
|---|---|
| Stable | |
| Stable | |
| Stable | |
| Healthy |
DXC's balance sheet is currently healthy, and its revenue, profitability and cash flow are stable.
MU Fundamentals
| Metric | Status |
|---|---|
| Strong | |
| Strong | |
| Strong | |
| Strong |
MU's revenue, profitability, cash flow and balance sheet are all currently strong.
DXC PE Valuation
| Level | PE | Price | Vs current |
|---|---|---|---|
| Forward | 5.7x | $14.85 | — |
| Cheap | 6.9x | $4.77 | -68% |
| Fair | 12x | $8.59 | -42% |
| Current | 22x | $14.85 | — |
| Expensive | 47x | $32.15 | +117% |
Historical ranges are pointers, not guarantees.
DXC's PE is in its fair range at 22x. On analysts' estimates for next year's earnings, today's price would be 5.7x, in its cheap range.
MU PE Valuation
| Level | PE | Price | Vs current |
|---|---|---|---|
| Forward | 4.6x | $798 | — |
| Cheap | 10x | $777 | -2.7% |
| Current | 11x | $798 | — |
| Fair | 22x | $1,646 | +106% |
| Expensive | 32x | $2,404 | +201% |
Historical ranges are pointers, not guarantees.
MU has the edge over DXC in the historical PE scenario, which offers more potential upside but is not a forecast.
DXC Forward outlook
| Metric | Outlook |
|---|---|
| Strongly improving | |
| Stable | |
| Stable | |
| Stable | |
| Limited | |
| Moderate |
Analysts expect DXC's earnings, revenue and profitability to hold roughly steady.
MU Forward outlook
| Metric | Outlook |
|---|---|
| Strongly improving | |
| Strong growth | |
| Strong growth | |
| Strongly improving | |
| Broad | |
| Moderate |
MU has the edge over DXC on the outlook, with more favorable earnings and revenue expectations.
DXC Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Forward | $2.58 | +274% |
| Q3 2026 | $0.69 | -66% |
| Q2 2026 | $0.74 | -64% |
| Q1 2026 | $0.10 | -95% |
| Q4 2025 | $2.32 | +$2.65 |
| Q3 2025 | $2.02 | +1088% |
| Q2 2025 | $2.05 | +377% |
| Q1 2025 | $2.10 | +357% |
| Q4 2024 | -$0.33 | +$1.48 |
DXC's earnings per share have fallen from their peak: $0.69 over the past year, against $3.03 in late 2022.
MU Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Forward | $174.95 | +135% |
| Q3 2026 | $74.33 | +879% |
| Q2 2026 | $44.17 | +693% |
| Q1 2026 | $21.18 | +405% |
| Q4 2025 | $10.52 | +201% |
| Q3 2025 | $7.59 | +984% |
| Q2 2025 | $5.57 | +$6.99 |
| Q1 2025 | $4.19 | +$7.64 |
| Q4 2024 | $3.49 | +$9.77 |
MU has the edge over DXC on earnings, with more consistent year-over-year improvement.
DXC Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $3B | -4% |
| Q2 2026 | $3B | -5.1% |
| Q1 2026 | $3.1B | -1.2% |
| Q4 2025 | $3.2B | -1% |
| Q3 2025 | $3.2B | -2.5% |
| Q2 2025 | $3.2B | -2.4% |
| Q1 2025 | $3.2B | -6.4% |
| Q4 2024 | $3.2B | -5.1% |
DXC's revenue fell from its 2019 peak and has held roughly level since: $3B last quarter, down 4% from the same quarter a year ago.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | 6.2% | -1.9 points |
| Q2 2026 | 5% | -1.8 points |
| Q1 2026 | 7.6% | +0.3 points |
| Q4 2025 | 8.2% | -0.6 points |
| Q3 2025 | 8% | -0.6 points |
| Q2 2025 | 6.8% | 0 points |
| Q1 2025 | 7.3% | -1.1 points |
| Q4 2024 | 8.9% | +1.3 points |
DXC's operating margin was 6.2% last quarter, down 1.9 points from the same quarter a year ago, near the bottom of its range since 2019.
MU Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $54.2B | +379% |
| Q2 2026 | $41.5B | +346% |
| Q1 2026 | $23.9B | +196% |
| Q4 2025 | $13.6B | +57% |
| Q3 2025 | $11.3B | +46% |
| Q2 2025 | $9.3B | +37% |
| Q1 2025 | $8.1B | +38% |
| Q4 2024 | $8.7B | +84% |
MU has the edge over DXC on sales, with more consistent year-over-year improvement.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | 81% | +48 points |
| Q2 2026 | 80% | +57 points |
| Q1 2026 | 68% | +46 points |
| Q4 2025 | 45% | +20 points |
| Q3 2025 | 32% | +13 points |
| Q2 2025 | 23% | +13 points |
| Q1 2025 | 22% | +19 points |
| Q4 2024 | 25% | +49 points |
MU has the edge over DXC on profitability, with a higher operating margin.
DXC Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | $143M | -61% |
| Q2 2026 | $359M | +151% |
| Q1 2026 | $169M | -29% |
| Q4 2025 | $359M | -37% |
| Q3 2025 | $365M | +137% |
| Q2 2025 | $143M | -25% |
| Q1 2025 | $238M | -1.7% |
| Q4 2024 | $568M | -15% |
DXC generated $1B in free cash flow over the past year, down 22% from the year before.
MU Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | $32.9B | +45543% |
| Q2 2026 | $17.6B | +951% |
| Q1 2026 | $5.5B | +$5.6B |
| Q4 2025 | $3B | +7853% |
| Q3 2025 | $72M | -75% |
| Q2 2025 | $1.7B | +322% |
| Q1 2025 | -$113M | +$52M |
| Q4 2024 | $38M | +$433M |
MU has the edge over DXC on cash flow, with more consistent year-over-year improvement.
DXC Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | -2.6% | -4.3M shares |
| 1 year | -9.6% | -17.2M shares |
| 3 years | -20% | -41.1M shares |
| 5 years | -36% | -90.4M shares |
| Available history | -37% | -94.1M shares |
DXC has the edge over MU on shareholder dilution, with a more favorable share count trend.
| Quarter | Spent |
|---|---|
| Q3 2026 | $61M |
| Q2 2026 | $71M |
| Q1 2026 | $61M |
| Q4 2025 | $64M |
| Q3 2025 | $76M |
| Q2 2025 | $48M |
| Q1 2025 | — |
| Q4 2024 | $12M |
DXC spent $257M buying back its own shares over the past year, up 89% from the year before.
MU Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | -0.2% | -2M shares |
| 1 year | +1.6% | +18M shares |
| 3 years | +4.6% | +50M shares |
| 5 years | +0.2% | +2M shares |
| Available history | +1.2% | +14M shares |
MU has 1.1B diluted shares, up 1.6% from a year ago.
| Quarter | Spent |
|---|---|
| Q3 2026 | — |
| Q2 2026 | — |
| Q1 2026 | $350M |
| Q4 2025 | $300M |
| Q3 2024 | $300M |
| Q2 2024 | — |
| Q1 2024 | — |
| Q4 2023 | — |
MU has spent almost nothing on buybacks in the past year.
DXC Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q3 2026 | 0.7x | Very low |
| Q2 2026 | 0.8x | Very low |
| Q1 2026 | 0.9x | Very low |
| Q4 2025 | 0.9x | Very low |
| Q3 2025 | 0.9x | Very low |
| Q2 2025 | 1.0x | Very low |
| Q1 2025 | 0.9x | Very low |
| Q4 2024 | 0.9x | Very low |
DXC's net debt is less than a year of its operating earnings (EBITDA).
MU Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q3 2026 | -0.3x | Net Cash |
| Q2 2026 | -0.3x | Net Cash |
| Q1 2026 | -0.1x | Net Cash |
| Q4 2025 | 0.1x | Very low |
| Q3 2025 | 0.3x | Very low |
| Q2 2025 | 0.3x | Very low |
| Q1 2025 | 0.5x | Very low |
| Q4 2024 | 0.6x | Very low |
MU has the edge over DXC on leverage, with a lower net debt burden relative to earnings.
DXC Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 64.6 | Neutral |
| Stochastic | 76.3 | Neutral |
DXC's weekly RSI is 65 (neutral) and its Stochastic is 76 (neutral).
MU Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 47.1 | Neutral |
| Stochastic | 26.9 | Neutral |
MU's weekly RSI is 47 (neutral) and its Stochastic is 27 (neutral).
DXC PE vs Technology Sector
| Metric | DXC | Sector median | Relative |
|---|---|---|---|
| PE | 22x | 28x | 23% below |
| PE % | 63 | 35 | 28 pts above |
DXC is trading at 22x earnings, a 23% discount to the Technology sector's median of 28x.
MU PE vs Technology Sector
| Metric | MU | Sector median | Relative |
|---|---|---|---|
| PE | 11x | 28x | 61% below |
| PE % | 18 | 35 | 17 pts below |
MU has the edge over DXC on valuation relative to its sector.
DXC Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $13.6 | 9.4% above |
| 20 week MA | $11.8 | 26% above |
| 50 week MA | $12.1 | 22% above |
| 100 week MA | $14.0 | 6.1% above |
| 200 week MA | $18.1 | 18% below |
DXC has the edge over MU on trend strength, trading above more of its moving averages.
MU Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $914.5 | 13% below |
| 20 week MA | $931.0 | 14% below |
| 50 week MA | $685.9 | 16% above |
| 100 week MA | $405.4 | 97% above |
| 200 week MA | $246.0 | 225% above |
MU has pulled back, but its long-term trend is still up: it's below its 8- and 20-week averages, but 225% above its 200-week average.
DXC Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $36.7 | $22.9 | -38% |
| 2021 | $22.9 | $32.6 | +42% |
| 2022 | $32.6 | $26.5 | -19% |
| 2023 | $26.5 | $22.9 | -14% |
| 2024 | $22.9 | $20.2 | -12% |
| 2025 | $20.2 | $15.1 | -25% |
| 2026 YTD | $15.1 | $14.9 | -1.7% |
DXC has finished four years in a row lower, and it's down 1.7% so far in 2026.
MU Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $54.0 | $70.6 | +31% |
| 2021 | $70.6 | $94.4 | +34% |
| 2022 | $94.4 | $50.2 | -47% |
| 2023 | $50.2 | $85.3 | +70% |
| 2024 | $85.3 | $88.6 | +3.9% |
| 2025 | $88.6 | $284.8 | +221% |
| 2026 YTD | $284.8 | $798.4 | +180% |
MU has the edge over DXC on returns for 2026, with the stronger performance.